Mazama Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Mazama Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-63,489	Closed	-$3.27M	–	211
2015 Q4	$3.27M	Buy	63,489 +19,919	+46%	+$966K	0.6%	52
2015 Q3	$1.86M	Sell	43,570 -5,256	-11%	-$254K	0.39%	73
2015 Q2	$2.22M	Buy	48,826 +5,707	+13%	+$230K	0.45%	75
2015 Q1	$1.64M	Sell	43,119 -27,192	-39%	-$934K	0.34%	91
2014 Q4	$1.99M	Buy	70,311 +44,304	+170%	+$1.23M	0.46%	70
2014 Q3	$657K	Buy	26,007 +24,861	+2,169%	+$655K	0.17%	156
2014 Q2	$33K	Sell	1,146 -1,879	-62%	-$45.5K	0.01%	234
2014 Q1	$78K	Sell	3,025 -5,841	-66%	-$156K	0.07%	98
2013 Q4	$228K	Buy	8,866 +3,516	+66%	+$85.4K	0.11%	134
2013 Q3	$143K	Sell	5,350 -9,030	-63%	-$215K	0.08%	135
2013 Q2	$353K	Buy	+14,380	New	+$286K	0.22%	117

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mazama Capital Management's PTLA Position: Q1 2016 in Review

Mazama Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 63,489 shares — an estimated $3.27M sold.

Mazama Capital Management first reported a position in PTLA in Q2 2013 and held it in 11 quarters. The position peaked at $3.27M in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

Mazama Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 63,489 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $3.27M.
Mazama Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 11 quarters.
Mazama Capital Management's Portola Pharmaceuticals, Inc. position peaked at $3.27M in Q4 2015.
167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.